Clinical trial

Modification Of Disease Outcome In COPD

NCT00158847

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2000-04-01

PhasePHASE4

Study timeline

Study start (unknown)2000-04-01Date precision: month

Registry last updated2006-01-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Diseaseunresolved

Interventions

fluticasone 500 mcgDRUG

fluticasone 500 mcg + salmeterol 50 mcgDRUG

Sponsors & collaborators

Leiden University Medical Centerlead sponsor

Academisch Ziekenhuis Groningencollaborator

The Netherlands Asthma Foundationcollaborator

Netherlands Organisation for Scientific Researchcollaborator

GlaxoSmithKlinecollaborator

Mapped research locations

GroningenNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00158847 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.